Compare · RST vs SNOW
RST vs SNOW
Side-by-side comparison of Rosetta Stone (RST) and Snowflake Inc. (SNOW): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RST and SNOW operate in Computer Software: Prepackaged Software (Technology), so they compete in similar markets.
- SNOW carries a market cap of $106.59B.
- SNOW has hit the wire 13 times in the past 4 weeks while RST has been quiet.
- SNOW has more recent analyst coverage (25 ratings vs 0 for RST).
- Company
- Rosetta Stone
- Snowflake Inc.
- Price
- -
- $307.54+4.94%
- Market cap
- -
- $106.59B
- 1M return
- -
- +18.23%
- 1Y return
- -
- +47.52%
- Industry
- Computer Software: Prepackaged Software
- Computer Software: Prepackaged Software
- Exchange
- NYSE
- NYSE
- IPO
- 2009
- 2020
- News (4w)
- 0
- 13
- Recent ratings
- 0
- 25
Snowflake Inc.
Snowflake Inc. provides cloud-based data platform in the United States and internationally. The company's platform offers Data Cloud, an ecosystem that enables customers to consolidate data into a single source of truth to drive meaningful business insights, build data-driven applications, and share data. Its platform is used by various organizations of various sizes in a range of industries. The company was formerly known as Snowflake Computing, Inc. and changed its name to Snowflake Inc. in April 2019. Snowflake Inc. was incorporated in 2012 and is headquartered in San Mateo, California.
Latest RST
- SEC Form SC 13G/A filed
- Uber Partners with Rosetta Stone to Include Language Learning in Popular Uber Rewards Program
- Navajo Language Renaissance Announces Launch of the Rosetta Stone Navajo Mobile App
- Rosetta Stone Announces Winners of the Emergent Bilingual Educators of the Year Award Program
- Rosetta Stone to Launch Emergent Bilingual Week
- SHAREHOLDER ALERT: WeissLaw LLP Reminds RST, GANS, and VAR Shareholders About Its Ongoing Investigations
- Lifshitz Law Firm, P.C. Announces Investigation of Akcea Therapeutics, Inc. (NASDAQ: AKCA), BMC Stock Holdings, Inc. (NASDAQ: BMCH), Builders FirstSource, Inc. (NASDAQ: BLDR), Cancer Genetics, Inc. (NASDAQ: CGIX), Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), Otelco Inc. (NASDAQ: OTEL), Rosetta Stone Inc. (NYSE: RST), Varian Medical Systems, Inc. (NYSE: VAR), and Yintech Investment Holdings Limited (NASDAQ: YIN)
- SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of IMMU, VRTU, RST, and CBMG Buyouts
- Moore Kuehn Encourages RST, AKCA, DCOM, and SBPH Investors to Contact Law Firm
- WeissLaw LLP Reminds MXIM, RST, and MR Shareholders About Its Ongoing Investigations
Latest SNOW
- EVP, Product Management Kleinerman Christian sold $8,995,800 worth of shares (29,986 units at $300.00) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 375,379 units (SEC Form 4)
- Snowflake to Present at Upcoming Investor Conferences
- Snowflake to Announce Financial Results for the Second Quarter of Fiscal 2027 on September 2, 2026
- Director Dageville Benoit sold $14,000,000 worth of shares (50,000 units at $280.00) as part of a pre-agreed trading plan and gifted 16,668 shares (SEC Form 4)
- SEC Form 144 filed by Snowflake Inc.
- Snowflake Advances the Trusted Agentic Enterprise Era with Unified Monitoring and Cost Management
- Director Slootman Frank exercised 300,000 shares at a strike of $8.88 and sold $82,323,691 worth of shares (300,000 units at $274.41) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by Snowflake Inc.
- SEC Form 144 filed by Snowflake Inc.
- SEC Form 4 filed by Chief Executive Officer Ramaswamy Sridhar